X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER CHEMOTHERAPY AND PHARMACOLOGY

期刊標題檢索 CANCER CHEMOTH 最新評論: Do you need the full map of World of Warcraft? (2023-11-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER CHEMOTHERAPY AND PHARMACOLOGY]您好,您是該頁面的第 54620 位訪客。

期刊簡介
期刊名稱CANCER CHEMOTHERAPY AND PHARMACOLOGY CANCER CHEMOTHERAPY AND PHARMACOLOGY
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
9.1

期刊簡稱CANCER CHEMOTH PHARM
ISSN0344-5704
E-ISSN1432-0843
h-index100
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.100.8690.721
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q272 / 272
Category: Medicine
Subcategory: Oncology
Q2124 / 404
Category: Medicine
Subcategory: Toxicology
Q245 / 133
Category: Medicine
Subcategory: Pharmacology
Q2115 / 313
Category: Medicine
Subcategory: Cancer Research
Q2102 / 230

自引率 (2023-2024)3.70%自引率趨勢
掲載範囲
Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.
官方網站https://www.springer.com/280
在線稿件提交https://www.editorialmanager.com/ccap
開放訪問No
出版商Springer Berlin Heidelberg
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1978
每年文章數120每年文章數趨勢
黃金OA百分比28.97%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3163/322
PHARMACOLOGY & PHARMACYSCIEQ2167/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0344-5704%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2.5 Month(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【CANCER CHEMOTHERAPY AND PHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498655
    PHYTOMEDICINE343697
    LIFE SCIENCES290206
    PHARMACOLOGICAL RESEARCH243468
    International Journal of Pharmaceutics242749
    European Journal of Pharmacology204544
    BIOCHEMICAL PHARMACOLOGY203056
    JOURNAL OF NATURAL PRODUCTS196864
    BRITISH JOURNAL OF PHARMACOLOGY165439
    MOLECULAR PHARMACEUTICS162981
  •  

    CANCER CHEMOTHERAPY AND PHARMACOLOGY CANCER CHEMOTHERAPY AND PHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CANCER CHEMOTHERAPY AND PHARMACOLOGY] 的評論撰寫評論
作者: 建柏mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-27 13:01:29 評論於
Do you need the full map of World of Warcraft?
(0) 讚! | 建柏mio

作者: 猫巷少女怀双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 11:18:54 評論於
Review speed: 2.0 | Submission hit rate: 75.0 Emphasized research directions: Oncology; Pharmacology; Chemotherapy experience sharing: A small review manuscript has been submitted for three weeks for the first time, but it is still editor assigned, and I feel it is too slow so I withdrew the manuscript. Then it was rejected by others, so I submitted it again later. The second submission was on 2023-05-17 submitted 2023-05-18 Reviewers Assigned (changed on 06-02 halfway) 2023-06-05 Under Review 2023-06-09 Reviewers Assigned (changed on 06-15, 06-23, 07-03, 07-10 halfway) 2023-07-17 minor revision (given ten days for minor revisions, with only one reviewer, editor pointed out that English level and abstract were too short, so I sent back a revised version, and it was returned on the 23rd. Then because of some formatting issues, it was returned immediately, and resubmitted on the 24th) 2023-07-24 Editor assigned 2023-07-27 Accept
(0) 讚! | 猫巷少女怀双

作者: 岭南正初


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-01 17:49:19 評論於
Any news?
(0) 讚! | 岭南正初

作者: 书生梦幻


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-06 21:01:33 評論於
Hello, how long does it take after online publication to officially be published?
(0) 讚! | 书生梦幻

作者: 金山沛容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-09 19:41:57 評論於
Hello, how much is the layout fee?
(0) 讚! | 金山沛容

作者: 元绿酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-30 17:01:41 評論於
Not necessary
(0) 讚! | 元绿酱大魔王

作者: 宗室忆安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-05 11:35:23 評論於
Does WB need the full original image?
(0) 讚! | 宗室忆安

作者: 风见妙晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-01 21:07:58 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Emphasized research direction: Cancer; Pharmacology experience sharing: The first review is very fast, about one week, minor revisions take about a month and a half, and once revised, it is accepted within half a day, very efficient
(0) 讚! | 风见妙晴

作者: Donald Catharine


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-11 11:49:02 評論於
Review speed: 1.0 | Submission hit rate: 75.0 
Research focus: Tumors; Experience sharing on chemotherapy: Submitted at the end of August, received reviewer comments in September requesting a small experiment, resubmitted in November, accepted within a week, and published by the end of December
(0) 讚! | Donald Catharine

作者: 玄冰姣妍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-21 12:54:42 評論於
Prepare the complete map of the World Bank
(0) 讚! | 玄冰姣妍

作者: 华清冬雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-11 20:19:12 評論於
Do you need the raw data?
(0) 讚! | 华清冬雁

作者: 华清冬雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-11 13:32:30 評論於
Do you want the raw data?
(0) 讚! | 华清冬雁

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:26:31 評論於
Try to make up for the experiment as much as possible if conditions allow. If it is really not possible, then carefully consider reasons for defense, but a humble and cautious attitude is essential. After all, there is also a certain rejection rate for major revisions
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:38:50 評論於
Issues related to experiments and writing articles
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 23:04:50 評論於
What questions do reviewers and journal editors generally ask?
(0) 讚! | 八坂篷蔚

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-24 08:05:27 評論於
The reviewer required me to conduct additional experiments, but my samples have already been used up/the experiment has already been completed. Will my paper be rejected if I directly state that my samples have been used up?
(0) 讚! | 龙鳞孝礼

作者: 小野寺英范


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-04 20:28:44 評論於
The paper has been accepted, with a total processing time of nearly 4 months. The editor-in-chief is very kind, and the reviewers are very professional, providing me with excellent insights for my paper. Overall, it is a very good journal!
(0) 讚! | 小野寺英范

作者: 小野寺英范


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-26 16:38:56 評論於
Review speed: 3.0
Emphasis on research direction: tumor; experience sharing on chemotherapy: I would like to ask everyone, what is the possibility of being rejected after major revision? The reviewer's comments were very good, although they gave a major revision, mainly focusing on modifying the discussion section. The major revision suggestions mainly provided some ideas from the reviewer, which I have all incorporated into the discussion section. It has been under review for 1 week
(0) 讚! | 小野寺英范

作者: Doreen Bertha


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-07-01 23:59:41 評論於
Have you got any news?
(0) 讚! | Doreen Bertha

作者: 元绿酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-13 19:00:22 評論於
It is an American magazine, not German one
(0) 讚! | 元绿酱大魔王

作者: 元绿酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-12 18:14:01 評論於
1 month after submission, received a message. Minor revisions were accepted, answered questions point to point as required, added some polish. It has been over half a month since resubmission, still under review. Probably the reviewers are not satisfied, it might get rejected
(0) 讚! | 元绿酱大魔王

作者: 终幕嘉俊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-06 21:16:17 評論於
How long after the online will be officially published
wind1060 2018-01-09 21:01:00 Posted: If the magazine does not choose open access, you do not need to pay for the layout. The editor is relatively friendly, the opinions of the reviewers are very professional. It took two months for a submitted article to be reviewed, and then 1.5 months were given for experiments and revisions. A new experiment was added, and the questions were answered carefully as required. After the revisions, it was reviewed for another half month and then accepted. Proof was received about half a month after acceptance, with a 2-day deadline for proofreading. The article was online the day after the proof was returned. Overall, the efficiency was quite high, and the Germans are indeed very responsible. Good luck to everyone!
(0) 讚! | 终幕嘉俊

作者: 葵花谷兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-06-20 17:09:49 評論於
Haha, scored a three-pointer!
(0) 讚! | 葵花谷兰

作者: 宫古晨星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-06 10:13:47 評論於
What happened later? It's been almost 3 weeks, have you not found any reviewers yet? It has been showing "Reviewers Assigned" the whole time, plus 10 days for delivery processing, a month wasted, the speed is really slow! I won't submit again next time!
(0) 讚! | 宫古晨星

作者: 葵花谷兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-08 13:49:39 評論於
Review Speed: 3.0 | Submission Hit Rate: 50.0
Experience Sharing: The review process of this journal is relatively slow (I submitted in early May and received the reviewer's comments in early August, almost 3 months), but the reviewers' comments are very professional, and the editors are very kind. Despite major revisions being requested, the editor expressed a willingness to accept the paper. After 1.5 months of revisions, carefully addressing the reviewers' comments and conducting 3 additional experiments, the paper was accepted 9 days after resubmission. The proofreading and online publication processes were both very fast. In conclusion, the slowest step was the initial review. I feel that the reviewers and editors were very helpful to me, and the editor was very nice
(0) 讚! | 葵花谷兰

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CANCER CHEMOTHERAPY AND PHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*